Simulation Study on the Stabilization Control Performance of Low-Calorific-Value Waste Combustion in Waste Incinerators.

To address the instability of low-calorific-value waste incineration processes and suppress the generation of toxic dioxins, this study examines a 600 t/day waste incineration furnace as a case study. Numerical simulations of the incineration process were conducted by using bed calculation software FLIC and Fluent. A waste incineration cleanliness index was defined, and the impact of the reduced calorific value of the incoming waste on the temperature distribution within the incineration furnace was explored.

Experimental study on the cyclic mineralization of CO enriched phase after absorption by a novel biphasic absorbent composed of DEEA and AEP.

The high energy consumption of Carbon Capture Utilization and Storage(CCUS) promotes the research of integrated absorption and mineralization technology. A novel DEEA/AEP biphasic absorbent is used to absorb [Formula: see text]. After phase separation, only one phase enriched with the absorption product is sent into the mineralization system, then reacts with [Formula: see text] to produce [Formula: see text] at normal temperature and pressure.

Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.

Background And Aims: Fecal microbiota transplantation (FMT) can improve the symptoms of nonalcoholic fatty liver disease (NAFLD) by restoring the gut microbiota. This study was aimed to evaluate the therapeutic effects of single-donor (SD) or multi-donor (MD) FMT in a mouse model of hepatic steatosis and explore the underlying mechanisms.

Methods: Fecal samples were collected from NAFLD patients and healthy controls with similar baseline characteristics, with gut microbiota analyzed.

Integrated analysis reveals the pivotal interactions between immune cells in the melanoma tumor microenvironment.

Melanoma is the most lethal type of skin cancer. Despite the breakthroughs in the clinical treatment of melanoma using tumor immunotherapy, many patients do not benefit from these immunotherapies because of multiple immunosuppressive mechanisms. Therefore, there is an urgent need to determine the mechanisms of tumor-immune system interactions and their molecular determinants to improve cancer immunotherapy.

CpG Island Methylator Phenotype Modulates the Immune Response of the Tumor Microenvironment and Influences the Prognosis of Pancreatic Cancer Patients.

Background: CpG island methylator phenotype (CIMP), featured with concurrent and widespread hypermethylation of a cluster of CpGs, has been reported to play an important role in carcinogenesis. Limited studies have investigated the role of CIMP in pancreatic cancer (PC). The aim of this study was to explore the CIMP in PC patients and its impact on the immune response of the tumor microenvironment and prognosis.

Identification of New Biomarker for Prediction of Hepatocellular Carcinoma Development in Early-Stage Cirrhosis Patients.

Background: Liver cirrhosis is one of the major drivers of hepatocellular carcinoma (HCC). In the present study, we aimed to identify and validate new biomarker for early prediction of HCC development in early-stage cirrhosis patients.

Methods: mRNA expression and clinical parameters of GSE63898, GSE89377, GSE15654, GSE14520, and TCGA-HCC cohort and ICGC-HCC cohort were downloaded for analysis.

Fecal microbiota transplantation ameliorates active ulcerative colitis.

Ulcerative colitis (UC) is a complex chronic pathological condition of the gut in which microbiota targeted treatment, such as fecal microbiota transplantation (FMT), has shown an encouraging effect. The aim of the present study was to investigate the efficacy and safety of FMT in patients with mild or moderate UC. A single-center, open-label study was designed, including 47 patients with mild or moderate active UC who received three treatments of fresh FMT via colonic transendoscopic enteral tubing within 1 week.

Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report.

Rationale: Fecal microbiota transplantation (FMT) is recognized as an emerging treatment through reconstruction of gut microbiota. Parkinson's disease is a neurodegenerative disorder, which is accompanied by constipation. Here we first reported a patient with Parkinson's disease and constipation that were obviously relieved after FMT.